Opioid physical dependence development: effects of single versus repeated morphine pretreatments and of subjects' opioid exposure history

Julian L. Azorlosa, Maxine L Stitzer, Mark K. Greenwald

Research output: Contribution to journalArticle

Abstract

In acute dependence, signs and symptoms of opioid withdrawal are precipitated when an opioid antagonist (naloxone) is administered following acute (e.g. single dose) pretreatment with a mu agonist. This study examined the influence of amount of previous opioid exposure, both immediate and remote, on intensity of precipitated withdrawal effects in an acute dependence model. Two groups of subjects, opioid abusers (n=20) and nonabusers (n=20), received either one 15 mg/70 kg IM morphine pretreatment or two such pretreatments spaced 24 h apart. Naloxone challenge (30 mg/70 kg) followed 4.33 h after the second pretreatment. There were clear effects of morphine pretreatment condition (single versus repeated 15 mg) on the intensity of precipitated withdrawal responses elicited by naloxone. More intense effects were seen after the repeated pretreatment, suggesting that physical dependence escalates with repeated opioid exposures spaced at appropriate intervals. Subjects with an opioid abuse history reported greater liking of agonist drug effects than did nonabusers, whereas nonabusers reported more sedating effects. However, an opioid abuse history did not influence the intensity of precipitated withdrawal symptoms and signs. The latter finding suggests that a previous opioid exposure history does not dramatically modulate initial stages of physical dependence development during subsequent opioid exposure episodes.

Original languageEnglish (US)
Pages (from-to)71-80
Number of pages10
JournalPsychopharmacology
Volume114
Issue number1
DOIs
StatePublished - Feb 1994

Fingerprint

Morphine
Opioid Analgesics
History
Naloxone
Substance Withdrawal Syndrome
Narcotic Antagonists
Signs and Symptoms
Pharmaceutical Preparations

Keywords

  • Acute physical dependence
  • Human abusers versus nonabusers
  • Morphine
  • Naloxone
  • Opioid drugs
  • Precipitated withdrawal

ASJC Scopus subject areas

  • Pharmacology

Cite this

Opioid physical dependence development : effects of single versus repeated morphine pretreatments and of subjects' opioid exposure history. / Azorlosa, Julian L.; Stitzer, Maxine L; Greenwald, Mark K.

In: Psychopharmacology, Vol. 114, No. 1, 02.1994, p. 71-80.

Research output: Contribution to journalArticle

@article{ee91952458da44feb91793674fd9c400,
title = "Opioid physical dependence development: effects of single versus repeated morphine pretreatments and of subjects' opioid exposure history",
abstract = "In acute dependence, signs and symptoms of opioid withdrawal are precipitated when an opioid antagonist (naloxone) is administered following acute (e.g. single dose) pretreatment with a mu agonist. This study examined the influence of amount of previous opioid exposure, both immediate and remote, on intensity of precipitated withdrawal effects in an acute dependence model. Two groups of subjects, opioid abusers (n=20) and nonabusers (n=20), received either one 15 mg/70 kg IM morphine pretreatment or two such pretreatments spaced 24 h apart. Naloxone challenge (30 mg/70 kg) followed 4.33 h after the second pretreatment. There were clear effects of morphine pretreatment condition (single versus repeated 15 mg) on the intensity of precipitated withdrawal responses elicited by naloxone. More intense effects were seen after the repeated pretreatment, suggesting that physical dependence escalates with repeated opioid exposures spaced at appropriate intervals. Subjects with an opioid abuse history reported greater liking of agonist drug effects than did nonabusers, whereas nonabusers reported more sedating effects. However, an opioid abuse history did not influence the intensity of precipitated withdrawal symptoms and signs. The latter finding suggests that a previous opioid exposure history does not dramatically modulate initial stages of physical dependence development during subsequent opioid exposure episodes.",
keywords = "Acute physical dependence, Human abusers versus nonabusers, Morphine, Naloxone, Opioid drugs, Precipitated withdrawal",
author = "Azorlosa, {Julian L.} and Stitzer, {Maxine L} and Greenwald, {Mark K.}",
year = "1994",
month = "2",
doi = "10.1007/BF02245446",
language = "English (US)",
volume = "114",
pages = "71--80",
journal = "Psychopharmacology",
issn = "0033-3158",
publisher = "Springer Verlag",
number = "1",

}

TY - JOUR

T1 - Opioid physical dependence development

T2 - effects of single versus repeated morphine pretreatments and of subjects' opioid exposure history

AU - Azorlosa, Julian L.

AU - Stitzer, Maxine L

AU - Greenwald, Mark K.

PY - 1994/2

Y1 - 1994/2

N2 - In acute dependence, signs and symptoms of opioid withdrawal are precipitated when an opioid antagonist (naloxone) is administered following acute (e.g. single dose) pretreatment with a mu agonist. This study examined the influence of amount of previous opioid exposure, both immediate and remote, on intensity of precipitated withdrawal effects in an acute dependence model. Two groups of subjects, opioid abusers (n=20) and nonabusers (n=20), received either one 15 mg/70 kg IM morphine pretreatment or two such pretreatments spaced 24 h apart. Naloxone challenge (30 mg/70 kg) followed 4.33 h after the second pretreatment. There were clear effects of morphine pretreatment condition (single versus repeated 15 mg) on the intensity of precipitated withdrawal responses elicited by naloxone. More intense effects were seen after the repeated pretreatment, suggesting that physical dependence escalates with repeated opioid exposures spaced at appropriate intervals. Subjects with an opioid abuse history reported greater liking of agonist drug effects than did nonabusers, whereas nonabusers reported more sedating effects. However, an opioid abuse history did not influence the intensity of precipitated withdrawal symptoms and signs. The latter finding suggests that a previous opioid exposure history does not dramatically modulate initial stages of physical dependence development during subsequent opioid exposure episodes.

AB - In acute dependence, signs and symptoms of opioid withdrawal are precipitated when an opioid antagonist (naloxone) is administered following acute (e.g. single dose) pretreatment with a mu agonist. This study examined the influence of amount of previous opioid exposure, both immediate and remote, on intensity of precipitated withdrawal effects in an acute dependence model. Two groups of subjects, opioid abusers (n=20) and nonabusers (n=20), received either one 15 mg/70 kg IM morphine pretreatment or two such pretreatments spaced 24 h apart. Naloxone challenge (30 mg/70 kg) followed 4.33 h after the second pretreatment. There were clear effects of morphine pretreatment condition (single versus repeated 15 mg) on the intensity of precipitated withdrawal responses elicited by naloxone. More intense effects were seen after the repeated pretreatment, suggesting that physical dependence escalates with repeated opioid exposures spaced at appropriate intervals. Subjects with an opioid abuse history reported greater liking of agonist drug effects than did nonabusers, whereas nonabusers reported more sedating effects. However, an opioid abuse history did not influence the intensity of precipitated withdrawal symptoms and signs. The latter finding suggests that a previous opioid exposure history does not dramatically modulate initial stages of physical dependence development during subsequent opioid exposure episodes.

KW - Acute physical dependence

KW - Human abusers versus nonabusers

KW - Morphine

KW - Naloxone

KW - Opioid drugs

KW - Precipitated withdrawal

UR - http://www.scopus.com/inward/record.url?scp=0028231931&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028231931&partnerID=8YFLogxK

U2 - 10.1007/BF02245446

DO - 10.1007/BF02245446

M3 - Article

C2 - 7846209

AN - SCOPUS:0028231931

VL - 114

SP - 71

EP - 80

JO - Psychopharmacology

JF - Psychopharmacology

SN - 0033-3158

IS - 1

ER -